Detalles de la búsqueda
1.
Feasibility and outcomes after dose reduction of immunochemotherapy in young adults with Burkitt lymphoma and leukemia: results of the BURKIMAB14 trial.
Haematologica
; 109(2): 543-552, 2024 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37560813
2.
Chemotherapy or allogeneic transplantation in high-risk Philadelphia chromosome-negative adult lymphoblastic leukemia.
Blood
; 137(14): 1879-1894, 2021 04 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33150388
3.
Age, CD34+ cell dose, conditioning and pre-transplant cytopenias can help predict transfusion support in lymphoma patients undergoing autologous stem cell transplantation.
Vox Sang
; 118(8): 681-689, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37356813
4.
Sequence matters: Total body irradiation (TBI)-based myeloablative conditioning with post-transplant cyclophosphamide may reduce the early nonrelapse mortality compared with pretransplant cyclophosphamide plus TBI.
Eur J Haematol
; 111(1): 146-153, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-37058419
5.
Prognosis of patients with acute lymphoblastic leukaemia relapsing after allogeneic stem cell transplantation.
Eur J Haematol
; 110(6): 659-668, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-36813736
6.
Respiratory virus infections after allogeneic stem cell transplantation: Current understanding, knowledge gaps, and recent advances.
Transpl Infect Dis
; 25 Suppl 1: e14117, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37585370
7.
Low Rate of Infectious Enterocolitis in Allogeneic Stem Cell Transplant Recipients with Acute Diarrhea: A Prospective Study by the GETH-TC.
Acta Haematol
; 146(2): 161-165, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36446336
8.
Prognostic heterogeneity of adult B-cell precursor acute lymphoblastic leukaemia patients with t(1;19)(q23;p13)/TCF3-PBX1 treated with measurable residual disease-oriented protocols.
Br J Haematol
; 196(3): 670-675, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34549416
9.
mRNA-1273 SARS-CoV-2 vaccine safety and COVID-19 risk perception in recently transplanted allogeneic hematopoietic stem cell transplant recipients.
Support Care Cancer
; 30(12): 9687-9690, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36169731
10.
Outcomes and prognostic factors of adults with refractory or relapsed T-cell acute lymphoblastic leukemia included in measurable residual disease-oriented trials.
Hematol Oncol
; 39(4): 529-538, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34405901
11.
Recommendations for screening, monitoring, prevention, and prophylaxis of infections in adult and pediatric patients receiving CAR T-cell therapy: a position paper.
Infection
; 49(2): 215-231, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-32979154
12.
Predicting Survival after Allogeneic Hematopoietic Cell Transplantation in Myelofibrosis: Performance of the Myelofibrosis Transplant Scoring System (MTSS) and Development of a New Prognostic Model.
Biol Blood Marrow Transplant
; 26(12): 2237-2244, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32717433
13.
When an HLA identical donor is not available in adults with hematological neoplasms: single-center comparison of single-unit cord blood transplantation and haploidentical-related PBSC transplantation with PTCy using a standardized conditioning platform (thiotepa-busulfan-fludarabine).
Ann Hematol
; 99(1): 157-165, 2020 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-31844931
14.
Low Rate of Invasive Fungal Infections During Induction and Consolidation Chemotherapy for Adults with De Novo Acute Myeloid Leukemia Without Anti-mold Prophylaxis: Single-Center 2002-2018 Empirical/Pre-emptive Approach.
Mycopathologia
; 185(4): 639-652, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32564177
15.
Effect of Sirolimus Exposure on the Need for Preemptive Antiviral Therapy for Cytomeglovirus Infection after Allogeneic Hematopoietic Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 25(5): 1022-1030, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30639821
16.
Thrombopoietin Receptor Agonists for Severe Thrombocytopenia after Allogeneic Stem Cell Transplantation: Experience of the Spanish Group of Hematopoietic Stem Cell Transplant.
Biol Blood Marrow Transplant
; 25(9): 1825-1831, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31152794
17.
Incidence and outcome after first molecular versus overt recurrence in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia included in the ALL Ph08 trial from the Spanish PETHEMA Group.
Cancer
; 125(16): 2810-2817, 2019 08 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31012967
18.
Frequency, characteristics, and outcome of PTLD after allo-SCT: A multicenter study from the Spanish group of blood and marrow transplantation (GETH).
Eur J Haematol
; 102(6): 465-471, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-30828868
19.
Bone marrow WT1 levels in patients with myeloid neoplasms treated with 5-azacytidine: Identification of responding patients.
Eur J Haematol
; 103(3): 208-214, 2019 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-31211880
20.
Bone Marrow WT1 Levels in Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myelogenous Leukemia and Myelodysplasia: Clinically Relevant Time Points and 100 Copies Threshold Value.
Biol Blood Marrow Transplant
; 24(1): 55-63, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28939453